DIGITAL THERAPEUTICS Trademark

Trademark Overview

On Wednesday, May 23, 2018, a trademark application was filed for DIGITAL THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the DIGITAL THERAPEUTICS trademark a serial number of 87932907. The federal status of this trademark filing is PREVIOUS ACTION/ALLOWANCE COUNT WITHDRAWN as of Tuesday, August 13, 2019. This trademark is owned by MODERNATX, INC.. The DIGITAL THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

scientific research and development in the fields of RNA-based pharmaceuticals, RNA-based medicine, RNA-based biologics, RNA-based biotherapeutics, RNA-based biosimilars and RNA-based therapeutics, namely, selection, preparation, analysis, modification, synthesization and delivery of mRNA by chemical, biological and biochemical means, and none of the foregoing research and development services pertaining to the use of digital technology designed to affect behavior or lifestyle changes or the use of digital technology to monitor dosing compliance or improve health outcomes other than by administration of RNA-based pharmaceuticals, RNA-based medicine, RNA-based biologics, RNA-based biotherapeutics, RNA-based biosimilars and RNA-based therapeutics
digital therapeutics

General Information

Serial Number87932907
Word MarkDIGITAL THERAPEUTICS
Filing DateWednesday, May 23, 2018
Status643 - PREVIOUS ACTION/ALLOWANCE COUNT WITHDRAWN
Status DateTuesday, August 13, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and Servicesscientific research and development in the fields of RNA-based pharmaceuticals, RNA-based medicine, RNA-based biologics, RNA-based biotherapeutics, RNA-based biosimilars and RNA-based therapeutics, namely, selection, preparation, analysis, modification, synthesization and delivery of mRNA by chemical, biological and biochemical means, and none of the foregoing research and development services pertaining to the use of digital technology designed to affect behavior or lifestyle changes or the use of digital technology to monitor dosing compliance or improve health outcomes other than by administration of RNA-based pharmaceuticals, RNA-based medicine, RNA-based biologics, RNA-based biotherapeutics, RNA-based biosimilars and RNA-based therapeutics

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, June 1, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMODERNATX, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Sunday, March 31, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, March 31, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sunday, March 31, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, March 31, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sunday, March 31, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, August 30, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 30, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 30, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 30, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 30, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, August 10, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 10, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 10, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 10, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, August 10, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, August 17, 2019DATA MODIFICATION COMPLETED
Thursday, August 15, 2019TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, August 13, 2019PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, August 13, 2019WITHDRAWN FROM PUB - MANAGING ATTORNEY REQUEST
Tuesday, July 30, 2019ASSIGNED TO LIE
Saturday, July 20, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 12, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 11, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 11, 2019TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, March 18, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, March 18, 2019FINAL REFUSAL E-MAILED
Monday, March 18, 2019FINAL REFUSAL WRITTEN
Thursday, February 7, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 6, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 6, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 6, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 6, 2018NON-FINAL ACTION E-MAILED
Monday, August 6, 2018NON-FINAL ACTION WRITTEN
Monday, July 23, 2018ASSIGNED TO EXAMINER
Friday, June 29, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, June 29, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, June 1, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, May 26, 2018NEW APPLICATION ENTERED

Related Keywords

therapeutics digital based biologics biosimilars technology medicine biotherapeutics pharmaceuticals development research